Expanding the Role of the Pharmacist: Immunoglobulin Therapy and Disease Management in Neuromuscular Disorders

Journal of Pharmacy Practice
Eric M TichyDrew Doyle

Abstract

Immunoglobulin G (IgG) is a commonly used treatment for chronic neuromuscular disorders (NMDs), such as chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. IgG therapy has also shown promise in treating other NMDs including myasthenia gravis, polymyositis, and dermatomyositis. IgG is administered as either intravenous immunoglobulin (IVIg) or subcutaneous immunoglobulin (SCIg), with SCIg use becoming more popular due to the treatment burden associated with IVIg. IVIg requires regular venous access; long infusions (typically 4-6 hours); and can result in systemic adverse events (AEs) for some patients. In contrast, SCIg can be self-administered at home with shorter infusions (approximately 1 hour) and fewer systemic AEs. As patient care shifts toward home-based settings, the role of the pharmacist is paramount in providing a continuation of care and acting as the bridge between patient and clinic. Pharmacists with a good understanding of current recommendations, dosing strategies, and administration routes for IgG therapy are best placed to support patients. The aims of this review are to highlight the evidence supporting IgG therapy in the treatment of NMDs and provide practical information on pat...Continue Reading

References

Jan 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FratinoR Haupt
Dec 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S KuwabaraT Hattori
Apr 19, 2007·The Annals of Pharmacotherapy·Hakan M Gürcan, A Razzaque Ahmed
Mar 18, 2008·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Melissa Leone, L Rad Dillon
Oct 10, 2008·The Journal of Allergy and Clinical Immunology·Francisco A Bonilla
Feb 25, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T HarboJ Jakobsen
Aug 21, 2009·Journal of the Peripheral Nervous System : JPNS·Filip EftimovIvo N van Schaik
Nov 4, 2009·Clinical and Experimental Immunology·S MisbahH D Ochs
Apr 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G O SkeieUNKNOWN European Federation of Neurological Societies
Apr 21, 2010·Journal of Clinical Immunology·W-Ludo van der PolLeonard H van den Berg
May 5, 2010·Neurology·Ted M BurnsUNKNOWN MG Composite and MG-QOL15 Study Group
Sep 23, 2010·Autoimmunity Reviews·Maria Giovanna DanieliArmando Gabrielli
Nov 13, 2010·Health and Quality of Life Outcomes·Sabine TworkJoachim Kugler
Jun 18, 2011·Journal of the Neurological Sciences·Yusuf A Rajabally, David A Kearney
Sep 16, 2011·Pediatric Rheumatology Online Journal·Yasushi KemmotsuTsutomu Saji
Mar 2, 2012·Current Neuropharmacology·Jessica Kraker, Saša A Zivković
Nov 10, 2012·Therapeutic Advances in Neurological Disorders·Kenneth C Gorson
Jan 9, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H MarkvardsenUNKNOWN Danish CIDP and MMN Study Group
Sep 21, 2013·American Journal of Nephrology·Jacques Dantal
Oct 15, 2013·Clinical and Experimental Immunology·J P Sieb
Nov 5, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H MarkvardsenJ Jakobsen
Dec 18, 2013·Immunotherapy·Melvin Berger
Apr 15, 2014·Journal of Clinical Immunology·Oliver HarschnitzLeonard H van den Berg
May 8, 2014·Journal of Clinical Immunology·Hessel Franssen
May 30, 2014·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·William C GerthArthur S Zbrozek
Jul 12, 2014·International Archives of Allergy and Immunology·Monika Saeedian, Inderpal Randhawa
Jul 22, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H MarkvardsenUNKNOWN Danish CIDP and MMN Study Group
Aug 26, 2014·Journal of Neurology·Dario CocitoUNKNOWN SCIg and Chronic Dysimmune Neuropathies Italian Network
Oct 22, 2014·Expert Review of Clinical Immunology·Majed AlabdaliVera Bril
Nov 25, 2014·Muscle & Nerve·Melvin Berger, Jeffrey A Allen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Élie HaddadAyman Kafal
© 2021 Meta ULC. All rights reserved